首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >The Human Fn14 Receptor Gene Is Up-Regulated in Migrating Glioma Cells in Vitro and Overexpressed in Advanced Glial Tumors
【2h】

The Human Fn14 Receptor Gene Is Up-Regulated in Migrating Glioma Cells in Vitro and Overexpressed in Advanced Glial Tumors

机译:人类Fn14受体基因在迁移神经胶质瘤细胞中上调并在晚期神经胶质瘤中过表达。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glioblastoma multiforme comprises the majority of human brain tumors. Patients with glioblastoma multiforme have poor survival rates, with an average life expectancy of <1 year. To assess possible mechanisms and to potentially target invasive glioma cells, we previously measured the gene expression profiles of glioma cells under migration-activated or passive states. One of the genes identified was Fn14, which encodes a cell surface receptor for the tumor necrosis factor superfamily member named TWEAK. In this study, we show that Fn14 gene expression is induced in migration-activated glioma cells >in vitro and significantly increases according to tumor grade >in vivo (>P < 0.01), with highest levels in glioblastoma tissue specimens. The >in situ expression pattern of Fn14 mRNA and protein was confined to primary glioma cells and the vascular endothelium, with no detection in adjacent normal brain. Conversely, TWEAK mRNA levels are low in glioblastoma samples relative to normal brain tissue. In addition, activation of the Fn14 receptor by addition of recombinant TWEAK resulted in increased glioma cell migration >in vitro. These results suggest a positive role for TWEAK and Fn14 in glioma progression and indicate that Fn14 gene expression may serve as a marker for invasive glioma cells.
机译:多形胶质母细胞瘤包括大多数人脑肿瘤。多形性胶质母细胞瘤患者生存率较差,平均预期寿命<1年。为了评估可能的机制并潜在地靶向侵袭性神经胶质瘤细胞,我们先前在迁移激活或被动状态下测量了神经胶质瘤细胞的基因表达谱。鉴定出的基因之一是Fn14,它编码称为TWEAK的肿瘤坏死因子超家族成员的细胞表面受体。在这项研究中,我们显示Fn14基因表达在迁移激活的神经胶质瘤细胞中被>体外诱导,并根据肿瘤的>体内(> P <0.01),在胶质母细胞瘤组织标本中含量最高。 Fn14 mRNA和蛋白的>原位表达模式仅限于原发性神经胶质瘤细胞和血管内皮细胞,在相邻的正常脑中未检测到。相反,相对于正常脑组织,胶质母细胞瘤样品中的TWEAK mRNA水平较低。此外,通过添加重组TWEAK激活Fn14受体导致胶质瘤细胞迁移增加>体外。这些结果表明TWEAK和Fn14在神经胶质瘤进展中具有积极作用,并表明Fn14基因表达可能充当侵袭性神经胶质瘤细胞的标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号